In fact, the Gas6/TAM system has recently emerged as an important player in the progression of liver fibrosis and as a novel biomarker of liver fibrosis (Bellan et al., 2019; Smirne et al., 2019). This evidence concerns the gene GAS6 and Hepatic fibrosis.